Hints and tips:
...The crunchy acronym was coined by Goldman Sachs for pharma companies GSK and Roche, Dutch chip company ASML, Switzerland’s Nestlé and Novartis, Danish drugmaker Novo Nordisk, France’s L’Oréal and LVMH, the...
...Not many managers are ready to do this — though some are beginning to ask their clients what they want (L&G and Aviva are ahead of the game)....
...The famed stockpicker (we’re of course talking about Buffett here) had his worst performance in a decade versus the S&P 500 in 2019 and this year is shaping up to be just as bad....
...One mystery here is the identity of the investment consortia buyers, “Gemstone Investment Holding Ltd” and “Allied Cigar Corporation, S.L”....
...GILD shares were up 8% in pre-market trading (now +3% vs S&P 500 2%), and as we have noted, remdesivir doesn’t really add much to our DCF....
...All this has left equity investors struggling to discern truth from fiction — helping to send volatility in the S&P 500 index to its third-highest level in seven years....
...L’Oréal Sector: cosmetics / HQ: Paris, France Key stat: Online sales jumped 53 per cent in the first quarter....
...Inaction has not been an issue since she rose to be GSK’ s chief executive in April last year....
...(WSJ) News round-up Iliad chairman fined €600,000 for insider dealing (FT) Allianz in exclusive talks to buy L&G’s general insurance unit (FT) Sprint, T-Mobile push back deadline to complete merger (...
...In the US Netflix has risen 50 per cent since the start of the year, making it the top performer in the S&P 500, while Victoria’s Secret owner L Brands is down 29 per cent, making it the second worst....
...pharma company”....
...In Australia the S&P/ASX 200 closed up 0.5 per cent....
...“There’s a lot of interest from both consumer goods companies and big pharma in bioprinting....
...Nestlé has stepped up its efforts to expand its skincare business by paying the Canadian pharma group Valeant $1.4bn for the rights to a number of cosmetics products....
...“We have long believed that the long-term future of the food industry is in the overlap between food and pharma or between food and beauty . . . and it could be argued that this transaction moves Nestlé...
...It has a net cash position, so could finance a buyback by gearing up its balance sheet and selling its stake in Sanofi, a pharma group....
...Lanco to borrow $5.6bn to add to India’s power capacity Lanco Infratech, an Indian electricity producer controlled by billionaire L....
...The move probably means that an overambitious pharma merger is now unlikely. The price is also reasonable....
...Philip L Letts Tom Glocer: You raise a very interesting point....
International Edition